FIELD: medicine; pharmaceuticals.
SUBSTANCE: disclosed is synthetic hepatoprotective agent of pyrimidine row. Offered application of L-ascorbate of 1-(2-hydroxyethyl)-4,6-dimethyl-1,2-dihydropyrimidin-2-one derivatives of formula I.
EFFECT: compound possesses the ability to reduce functional and structural disorders of hepatocytes and providing faster recovery of structure and function of liver at toxic hepatitis; clinical effectiveness in terms of AlAT and AcAT higher than that of xymedone.
1 cl, 2 tbl
formula I
| Title | Year | Author | Number |
|---|---|---|---|
| HEPATOPROTECTIVE AGENT FROM ALGAE | 2013 |
|
RU2528898C1 |
| HEPATOPROTECTIVE AGENT FROM ALGAE | 2017 |
|
RU2667472C1 |
| PHYSICAL PERFORMANCE STIMULATING AGENT | 2013 |
|
RU2515247C1 |
| HEPATOPROTECTIVE AGENT FOR PROPHYLAXIS OF TETRACYCLINE LIVER DAMAGE | 0 |
|
SU1822772A1 |
| METHOD OF TREATING ANIMALS WITH RADIATION SICKNESS | 2024 |
|
RU2836843C1 |
| AN AQUEOUS SOLUTION SHOWING HEPATOPROTECTIVE EFFECT | 1996 |
|
RU2111746C1 |
| HEPATOPROTECTIVE SUBSTANCE | 2015 |
|
RU2614691C2 |
| AGENT POSSESSING ANTIARRHYTHMIC AND HEPATOPROTECTIVE PROPERTIES | 2011 |
|
RU2469720C1 |
| HEPATOPROTECTOR | 2010 |
|
RU2444569C1 |
| PHARMACEUTICAL COMPOSITION ELICITING HEPATOPROTECTIVE EFFECT AND MEDICINAL AGENT | 2003 |
|
RU2257208C1 |
Authors
Dates
2016-07-10—Published
2015-05-26—Filed